ArticleBone marrow transplantation2022

Long-term survival with mixed chimerism in patients with AML and MDS transplanted after conditioning with targeted busulfan, fludarabine, and thymoglobulin.

Albert C Yeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.